Approximately three quarters (76.9%) of PIK3CA wild-type tumours had pAKT levels that mimicked those of mutant lesions suggesting that AKT activity in MBCs is driven by genomic-dependent and independent events (Fig. 3b). The gene discussed is AKT1; the disease is neoplasm.